Etiological Profile of Hyperbilirubinemia in Full Term Neonates Requiring Exchange Transfusion
DOI:
https://doi.org/10.54112/bcsrj.v6i5.1736Keywords:
Neonatal hyperbilirubinemia, exchange transfusion, ABO incompatibility, Rh incompatibility, G6PD deficiencyAbstract
Neonatal hyperbilirubinemia, characterized by elevated serum bilirubin, is common in full-term neonates, with severe cases requiring exchange transfusion to prevent complications like kernicterus. This study explores the etiological factors necessitating this intervention at Ayub Teaching Hospital, Abbottabad. Objective: To identify and analyze etiological factors of hyperbilirubinemia requiring exchange transfusion in full-term neonates. Methods: A descriptive cross-sectional study was conducted at Neonatology Unit, Ayub Teaching Hospital, Abbottabad, from 2 December 06 May 2025, enrolling 385 full-term neonates (gestational age 37–42 weeks) with serum bilirubin >19.5 mg/dL. Data on demographics, clinical profiles, and etiologies were collected and analyzed using SPSS version 22. Results: ABO incompatibility (36.1%) was the leading cause, followed by Rh incompatibility (24.2%), G6PD deficiency (11.7%), sepsis (10.6%), and intracranial bleeding (3.4%). Unidentified causes accounted for 14.0%. Most neonates (93.8%) were discharged stable post-transfusion. Conclusion: ABO and Rh incompatibilities predominate, highlighting the need for enhanced antenatal screening and early neonatal surveillance to reduce exchange transfusion necessity.
Downloads
References
Mir, N.Y. and Zaman, B.U., 2024. Clinico-etiological profile of neonates with neonatal hyperbilirubinmemia treated with double volume exchange transfusion. International Journal of Contemporary Pediatrics, 11(7), p.1.
Lobo, A., Shanbhag, S. and Paul, S., 2023. Clinical profile of term neonates requiring intervention for hyperbilirubinemia. Muller Journal of Medical Sciences and Research, 14(1), pp.77-80.
Boskabadi, H., Khodashenas, E., Bagheri, F., Behgam, N. and Zakerihamidi, M., 2022. Evaluation of hematologic factors and bilirubin following exchange transfusion in neonatal hyperbilirubinemia. Transfusion and Apheresis Science, 61(5), p.103451.
Deger, İ. and İlter, S., 2022. Exchange transfusion in indirect hyperbilirubinemia: A single center experience. Harran Üniversitesi Tıp Fakültesi Dergisi, 19(2), pp.388-393.
Dey, S.K., Jahan, S., Jahan, I., Islam, M.S., Shabuj, M.K. and Shahidullah, M., 2021. Exchange transfusion for hyperbilirubinemia among term and near term in NICU of a tertiary care hospital of Bangladesh: Findings from a prospective study. Euroasian journal of hepato-gastroenterology, 11(1), p.21.
Wiley, S., Kaul, V., Adunka, O.F., Iwamoto, L., Nutt, R., Coverstone, K., Burk, P. and Joint Committee on Infant Hearing, 2024. Hyperbilirubinemia Requiring Exchange Transfusion as a Risk Factor for Later-Onset Hearing Loss. Journal of early hearing detection and intervention, 9(2), p.1.
Janardhanan, A., Raikar, P.S., Varghese, A., Phadke, A.K. and Kumble, A., 2024. Clinical Profile and Outcomes of Neonates with Hyperbilirubinemia Undergoing Double Volume Exchange Transfusion-A Single Centre Experience. Journal of Nepal Paediatric Society, 44(3), pp.11-15.
Yadav, S.K., Giri, A. and Khanal, B., 2021. Evaluation of risk factors for exchange range hyperbilirubinemia in neonates from Eastern part of Nepal. Journal of Nepal Paediatric Society, 41(1), pp.67-72.
DEGER, İ. and İLTER, S., 2021. Exchange Transfusion in Indirect Hyperbilirubinemia: A Single Center Experience İndirekt Hiperbilirubinemide Exchange Transfüzyon Uygulanması: Tek Merkez Deneyimi. ethics, 442.
Slaughter, J.L., Kemper, A.R. and Newman, T.B., 2022. Technical report: diagnosis and management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics, 150(3), p.e2022058865.
Routray, S.S., Behera, R., Mallick, B., Acharya, D., Sahoo, J.P., Kanungo, G.N. and Pati, B., 2021. The spectrum of hemolytic disease of the newborn: evaluating the etiology of unconjugated hyperbilirubinemia among neonates pertinent to immunohematological workup. Cureus, 13(8).
Singh, S.N., Tripathi, S., Kumar, M., Bhreguvanshi, A. and Chandra, T., 2021. Serum bilirubin trend, hematological and clinical profile of late preterm and term neonates with unconjugated hyperbilirubinemia-A prospective observational study. Clinical Epidemiology and Global Health, 10, p.100680.
Patra, K. and Mahapatra, S., 2024. Effectiveness of Double-volume Exchange Transfusion in Neonates with Hyperbilirubinemia: A Single-center Experience. Global Journal of Transfusion Medicine, 9(2), pp.130-133.
Asaye, S., Bekele, M., Getachew, A., Fufa, D., Adugna, T. and Tadasa, E., 2023. Hyperbilirubinemia and Associated Factors Among Neonates Admitted to the Neonatal Care Unit in Jimma Medical Center. Clinical Medicine Insights: Pediatrics, 17, p.11795565231193910.
Aga, M., Memar, E.H.E. and Mir, N.Y., 2025. Clinical profile of neonatal hyperbilirubinemia in children medical centre Tehran. International Journal of Community Medicine and Public Health, 12(1), p.263.
Kotadiya, E.S., Shah, G. and Nainiwal, L., 2024. Prospective Study of Distribution of Different Causes of Pathological Unconjugated Hyperbilirubinemia Risk Factor and Outcome. Res. J. Med. Sci, 18, pp.453-459.
Pandey, A.K., Jadhav, J. and Upadhyay, S., 2023. Clinico-Investigative Profile of Prolonged Hyperbilirubinemia in Newborns Presenting to Tertiary Health-Care Setup in Rural Maharashtra. Journal of Neonatology, 37(1), pp.49-58.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Muhammad Faizullah Khan, Asif Nawaz, Wajid Khan, Vildan Zaheer Abbasi, Sadiq Amin, Farhan Zeb Khan

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.